Literature DB >> 17972513

Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma.

Hiroyoshi Matsuoka1, Akihisa Nakamura, Tadahiko Masaki, Masanori Sugiyama, Toshiaki Nitatori, Yasuo Ohkura, Atsuhiko Sakamoto, Yutaka Atomi.   

Abstract

AIM: The purpose of this study was to determine the optimal diagnostic criteria for lateral pelvic lymph node metastasis in patients with rectal carcinoma. PATIENTS AND METHODS: From July 1997 to June 2005, fifty-one patients with locally advanced middle or lower rectal carcinoma underwent preoperative MRI examination, followed by total mesorectal excision with lateral pelvic node dissection. Factors of lateral pelvic lymph nodes evaluated were size, shape and internal structure. The size of lymph nodes was measured in both long and short axis diameters. The shape of lymph nodes was categorized into ovoid or irregular. The internal structure of lymph nodes was categorized into homogeneous or non-homogeneous. Optimal preoperative criteria on MRI were clarified by area under receiver operating characteristic curves (AUC). To clarify the optimal diagnostic criteria for diagnosing lateral pelvic lymph node metastasis, these basic four categories were analyzed. Subsequently, combined criteria comprising 11 categories were also evaluated to clarify optimal criteria.
RESULTS: Detection of lateral pelvic lymph node on MRI was significantly higher in the metastatic group. The basic four categories were evaluated to define each optimal criterion for metastasis. In category 1, the optimal criteria for long axis diameter of 10 mm or larger showed the largest AUC of 0.711. In category 2 (short axis diameter), the criterion of 5 mm or larger showed the largest AUC of 0.736. In category 3, an ovoid shape showed an AUC of 0.722. In category 4, heterogeneity of the internal structure gave the largest AUC of 0.708. Based on these results, fifteen categories (category 1-15) were defined. Among them, category 8 (an ovoid shape with a short axis diameter) showed the largest AUC of 0.75, representing 67% sensitivity, 83% specificity, and 78% overall accuracy.
CONCLUSION: An ovoid shape with a transverse axis diameter of 5 mm or larger on MRI was considered as the optimal criterion for diagnosing lateral lymph node metastasis in patients with rectal carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17972513

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

1.  Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.

Authors:  Seok-Byung Lim; Chang Sik Yu; Chan Wook Kim; Yong Sik Yoon; Seong Ho Park; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2013-08-14       Impact factor: 2.571

2.  Improving prediction of lateral node spread in low rectal cancers--multivariate analysis of clinicopathological factors in 1,046 cases.

Authors:  Kok-Yang Tan; Seiichiro Yamamoto; Shin Fujita; Takayuki Akasu; Yoshihiro Moriya
Journal:  Langenbecks Arch Surg       Date:  2010-04-02       Impact factor: 3.445

3.  Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.

Authors:  Shimpei Ogawa; Jin-Ichi Hida; Hideyuki Ike; Tetsushi Kinugasa; Mitsuyoshi Ota; Eiji Shinto; Michio Itabashi; Takahiro Okamoto; Masakazu Yamamoto; Kenichi Sugihara; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2017-07-31       Impact factor: 2.571

4.  Utility of Preoperative Imaging for Predicting Pelvic Lateral Lymph Node Metastasis in Lower Rectal Cancer.

Authors:  Koji Numata; Yusuke Katayama; Sho Sawazaki; Akio Higuchi; Soichiro Morinaga; Yasushi Rino; Munetaka Masuda; Manabu Shiozawa
Journal:  Indian J Surg Oncol       Date:  2019-06-03

Review 5.  The role of lateral lymph node dissection in the management of lower rectal cancer.

Authors:  Ziting Wang; Kep Yong Loh; Kok-Yang Tan; Emile Chung-Hou Woo
Journal:  Langenbecks Arch Surg       Date:  2011-11-22       Impact factor: 3.445

6.  Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.

Authors:  Yukiharu Hiyoshi; Yuji Miyamoto; Yuki Kiyozumi; Kojiro Eto; Yohei Nagai; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Naoya Yoshida; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2019-08-12       Impact factor: 3.402

7.  Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.

Authors:  Yuki Sekido; Junichi Nishimura; Shiki Fujino; Takayuki Ogino; Norikatsu Miyoshi; Hidekazu Takahashi; Mamoru Uemura; Naotsugu Haraguchi; Taishi Hata; Chu Matsuda; Tsunekazu Mizushima; Kohei Murata; Junichi Hasegawa; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2019-10-08       Impact factor: 2.549

8.  Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer.

Authors:  Shin Fujita; Seiichiro Yamamoto; Takayuki Akasu; Yoshihiro Moriya
Journal:  Int J Colorectal Dis       Date:  2009-04-23       Impact factor: 2.571

9.  Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer.

Authors:  Yusuke Yamaoka; Yusuke Kinugasa; Akio Shiomi; Tomohiro Yamaguchi; Hiroyasu Kagawa; Yushi Yamakawa; Masakatsu Numata; Akinobu Furutani
Journal:  Int J Colorectal Dis       Date:  2017-07-31       Impact factor: 2.571

10.  Efficacy of positron emission tomography in diagnosis of lateral lymph node metastases in patients with rectal Cancer: a retrospective study.

Authors:  Ryohei Yukimoto; Mamoru Uemura; Takahiro Tsuboyama; Tsuyoshi Hata; Shiki Fujino; Takayuki Ogino; Norikatsu Miyoshi; Hidekazu Takahashi; Taishi Hata; Hirofumi Yamamoto; Tsunekazu Mizushima; Akira Kida; Mamoru Furuyashiki; Yuichiro Doki; Hidetoshi Eguchi
Journal:  BMC Cancer       Date:  2021-05-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.